The Print

Game Development Companies Specializing in Multiplayer Games: How NipsApp Game Studios and Ubisoft Reflect a Changing Industry

Multiplayer game development is no longer limited to large publishers. It is now delivered through a mix of publishers and ...

Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties

Ad hoc announcement pursuant to Art. 53 LRExclusive licensing agreement includes USD 40 million upfront comprising USD 30 million in cash and USD ...

Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and ChinaNew ...

Santhera Pharmaceuticals Holding AG: Santhera Licenses AGAMREE (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 ...

Ad hoc announcement pursuant to Art. 53 LR Exclusive licensing agreement includes USD 40 million upfront comprising USD 30 million in cash and USD 10 million equity investment at CHF 14.91 per share ...
Tax Guru

Auditor–Board Communication Failures: NFRA issues Compliance Warning

NFRA held that weak, undocumented communication between auditors and governance bodies violates auditing standards and governance duties, requiring structured two-way ...